BDMD Baird Medical Investment Holdings Ltd Annual reports only
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1982444 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-39.2%
TTM net income YoY-319.0%
TTM EPS YoY-271.9%
Revenue 3-yr CAGR-13.7%
Net income 3-yr CAGR—
Margins
Gross margin83.8%
Operating margin-113.7%
Net margin-121.0%
FCF margin-6.2%
EBITDA margin-108.8%
Returns
ROE-76.8%
ROA-36.9%
ROIC (approx.)-50.1%
Asset turnover0.31x
Leverage & solvency
Liabilities / assets55.2%
Debt / equity0.28x
Current ratio1.70x
Interest coverage-72.33x
Cash quality & payout
Operating cash flow / net income0.05x
Accruals ratio-35.1%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY2022*2022-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $22.54M | $37.04M | $31.46M | $35.09M |
| Cost of revenue | $3.65M | $4.38M | $4.23M | $7.05M |
| Gross profit | $18.88M | $32.65M | $27.23M | $28.04M |
| R&D expense | $20.13M | $6.17M | $4.27M | $3.86M |
| SG&A expense | $14.12M | $7.10M | $8.55M | $6.96M |
| Operating income | -$25.63M | $15.32M | $11.86M | $13.63M |
| Interest expense | $354,341 | $388,613 | $227,923 | $299,269 |
| Pretax income | -$26.37M | $14.09M | $12.36M | $14.52M |
| Income tax | $1.17M | $1.49M | $1.70M | $1.75M |
| Net income | -$27.28M | $12.45M | $10.55M | $12.57M |
| EBITDA | -$24.53M | $16.45M | $12.88M | $14.55M |
| EPS (basic) | -0.98 | 0.57 | 0.51 | 0.49 |
| EPS (diluted) | -0.98 | 0.57 | 0.51 | 0.49 |
| Weighted avg. shares (diluted) | 27.79M | 21.83M | 20.59M | 25.56M |
| Balance sheet | ||||
| Cash & equivalents | $178,321 | $2.97M | $1.51M | $1.71M |
| Receivables | $42.53M | $46.58M | $31.10M | — |
| Inventory | $1.09M | $1.30M | $1.14M | — |
| Current assets | $54.97M | $61.42M | $40.08M | — |
| PP&E, net | $6.37M | $7.14M | $6.14M | — |
| Goodwill | $60,303 | $57,772 | $59,375 | — |
| Intangibles | $8,626 | $16,528 | $25,479 | — |
| Total assets | $69.70M | $77.96M | $56.71M | — |
| Current liabilities | $32.36M | $34.62M | $18.98M | — |
| Short-term debt | $2.64M | $867,772 | $817,485 | — |
| Long-term debt | $6.09M | $3.44M | $1.61M | — |
| Total debt | $8.72M | $4.31M | $2.43M | — |
| Total liabilities | $38.48M | $38.20M | $21.00M | — |
| Shareholders' equity | $31.37M | $39.66M | $35.75M | $25.78M |
| Net debt | $8.54M | $1.34M | $920,580 | — |
| Shares outstanding | 30.75M | 25.56M | 29.41M | — |
| Cash flow statement | ||||
| Operating cash flow | -$1.34M | -$6.31M | -$1.02M | $485,968 |
| Capital expenditure | $42,315 | $2.85M | $2.64M | $5.91M |
| Free cash flow | -$1.39M | -$9.17M | -$3.66M | -$5.42M |
| Investing cash flow | -$42,315 | -$2.47M | -$2.65M | -$5.92M |
| Financing cash flow | -$1.39M | $10.33M | $3.48M | $4.41M |
| Depreciation & amortization | $1.10M | $1.14M | $1.01M | $916,115 |
| Stock-based compensation | $17.47M | $0 | $0 | — |
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.